| abstract |
The present invention provides compositions and uses thereof for treating cancer with DAST, 4 {4- [3- (4-chloro-3-trif luoromethyl phenyl) -ureido] -3 -fluorophenoxy} -pyridine-2-carboxylic acid methylamide of the formula I, including all polymorphs, hydrates, pharmaceutically acceptable salts, metabolites, prodrugs, solvates or combinations thereof. Any cancer can be treated, including cancers that have acquired resistance to another therapeutic agent, such as kinase inhibitors. DAST can also be used to treat cancers which have become refractory to other chemotherapeutic agents. |